Checked
CV Sciences, Inc.
OTC: CVSI · Pharmaceutical Preparations · San Diego, CA
- Revenue
- $13.79M
- -12.2% vs. prior year
- Net income
- -$958K
- -6.9% net margin
- Total assets
- $6.96M
- Diluted EPS
- -$0.01
Company details
As reported to the SEC
- SEC CIK
- 1510964
- Stock
- OTC: CVSI
- Legal Entity Identifier (LEI)
- 549300CTTCLKOE31VK58
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 9530 Padgett Street, Suite 107, San Diego, CA 92126
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- Non-accelerated filer, Smaller reporting company
- Phone
- (866) 290-2157
- Employer ID (EIN)
- 80-0944970
- Last annual report
- 03/26/2026
- Last quarterly report
- 08/13/2026
Formerly: CannaVEST Corp. (until 01/04/2016); Foreclosure Solutions, Inc. (until 11/30/2012)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | $13.79M | $15.71M | $16M | $16.2M | $20.05M |
| Gross profit | $6.75M | $7.17M | $7.08M | $5.55M | $8.62M |
| Operating income | -$470K | -$2.19M | $3.36M | -$6.85M | -$18.45M |
| Net income | -$958K | -$2.39M | $3.1M | -$8.21M | -$15.55M |
| Diluted earnings per share | -$0.01 | -$0.01 | $0.02 | -$0.07 | -$0.14 |
| Research and development | $122K | $118K | $151K | $307K | $1.19M |
| Total assets | $6.96M | $7.93M | $9.2M | $12.74M | $18.07M |
| Total liabilities | $5.49M | $6.13M | $6.3M | $13.51M | $14.52M |
| Shareholders' equity | $1.47M | $1.79M | $2.9M | -$777K | $3.54M |
| Cash and cash equivalents | $278K | $454K | $1.32M | $611K | $1.38M |
| Long-term debt | $387K | $0 | Not reported | Not reported | $0 |
| Cash from operations | -$407K | -$861K | $2.25M | -$1.89M | -$7.49M |
| Capital expenditures | $109K | $18K | $0 | $0 | $35K |
Subsidiaries
3 companies that CV Sciences, Inc. owns or controls, as listed in its SEC annual report (Exhibit 21), GLEIF ownership records or USAspending
| Subsidiary | Listed in |
|---|---|
| Cultured Foods Sp. z.o.o. | SEC 10-K |
| Elevated Softgels LLC | SEC 10-K |
| Star Sky Foods, LLC | SEC 10-K |
Recent filings
149 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
2 insider ownership reports (Forms 3, 4, 5 and 144) were filed about CV Sciences, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is CV Sciences, Inc.'s CIK number?
- CV Sciences, Inc.'s SEC Central Index Key (CIK) is 1510964.
- What is CV Sciences, Inc.'s stock ticker?
- CV Sciences, Inc. trades as OTC: CVSI.
- What was CV Sciences, Inc.'s revenue?
- CV Sciences, Inc. reported revenue of $13.79M for the fiscal year ended Dec 31, 2025, -12.2% from the year before.
- When does CV Sciences, Inc.'s fiscal year end?
- CV Sciences, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is CV Sciences, Inc. headquartered?
- CV Sciences, Inc.'s principal executive office on file with the SEC is in San Diego, CA.
- What companies does CV Sciences, Inc. own?
- CV Sciences, Inc. lists 3 subsidiaries in its SEC filings and other public records, including Cultured Foods Sp. z.o.o., Elevated Softgels LLC, Star Sky Foods, LLC.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026